Pardis Ziaeefar

1.0k total citations
17 papers, 73 citations indexed

About

Pardis Ziaeefar is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Urology. According to data from OpenAlex, Pardis Ziaeefar has authored 17 papers receiving a total of 73 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Infectious Diseases and 4 papers in Urology. Recurrent topics in Pardis Ziaeefar's work include Kidney Stones and Urolithiasis Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Poisoning and overdose treatments (2 papers). Pardis Ziaeefar is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Poisoning and overdose treatments (2 papers). Pardis Ziaeefar collaborates with scholars based in Iran, Australia and Norway. Pardis Ziaeefar's co-authors include Nasim Zamani, Hossein Hassanian‐Moghaddam, Ali Hashemi, Narjess Bostanghadiri, Davood Darban‐Sarokhalil, Fatemeh Sameni, Mohammad Mahmoudi, Moein Zangiabadian, Alireza Abrishami and Fariba Farnaghi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and BioMed Research International.

In The Last Decade

Pardis Ziaeefar

15 papers receiving 73 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pardis Ziaeefar Iran 6 19 17 14 11 11 17 73
Hormat Rahimzadeh Iran 6 26 1.4× 37 2.2× 10 0.7× 11 1.0× 35 3.2× 13 111
Akash Sharma India 7 7 0.4× 9 0.5× 7 0.5× 6 0.5× 6 0.5× 14 119
Edward Gaynor United Kingdom 3 13 0.7× 9 0.5× 35 2.5× 4 0.4× 25 2.3× 12 99
Paloma Oliver Spain 7 16 0.8× 8 0.5× 4 0.3× 9 0.8× 16 1.5× 33 109
Ailbhe Tarrant Ireland 5 59 3.1× 21 1.2× 19 1.4× 4 0.4× 4 0.4× 11 118
Nicolas De Schryver Belgium 6 10 0.5× 7 0.4× 5 0.4× 3 0.3× 8 0.7× 12 77
Vishwanath Biradar Australia 5 11 0.6× 6 0.4× 8 0.6× 16 1.5× 11 1.0× 9 116
Robin Neubauer United States 4 9 0.5× 5 0.3× 35 2.5× 5 0.5× 8 0.7× 5 78
Jodie L. Hurwitz United States 10 5 0.3× 9 0.5× 2 0.1× 14 1.3× 7 0.6× 23 295
Marie-Hélène Masse Canada 6 15 0.8× 8 0.5× 4 0.3× 6 0.5× 4 0.4× 12 94

Countries citing papers authored by Pardis Ziaeefar

Since Specialization
Citations

This map shows the geographic impact of Pardis Ziaeefar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pardis Ziaeefar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pardis Ziaeefar more than expected).

Fields of papers citing papers by Pardis Ziaeefar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pardis Ziaeefar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pardis Ziaeefar. The network helps show where Pardis Ziaeefar may publish in the future.

Co-authorship network of co-authors of Pardis Ziaeefar

This figure shows the co-authorship network connecting the top 25 collaborators of Pardis Ziaeefar. A scholar is included among the top collaborators of Pardis Ziaeefar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pardis Ziaeefar. Pardis Ziaeefar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Rahmati, Maryam, et al.. (2025). Prolactin levels and chronic kidney disease and the subsequent risk of cardiovascular events: A long term population based cohort study. Scientific Reports. 15(1). 7198–7198. 1 indexed citations
3.
Basiri, Abbas, et al.. (2024). Determination of the kidney stone composition using infrared spectroscopy in Iran at a national referral center during 2019–2023. Asian journal of urology. 12(1). 72–78. 2 indexed citations
4.
Ziaeefar, Pardis, et al.. (2024). Neck Pain Severity and Work Ability Index: A Study of Tehran Dental Students. Iranian Rehabilitation Journal. 22(2). 265–276. 1 indexed citations
5.
Madani, Ali Hamidi, et al.. (2023). Evaluation of the frequency of metabolic syndrome and assessment of cardiometabolic index among men with erectile dysfunction: a prospective cross-sectional study. Journal of Diabetes & Metabolic Disorders. 22(2). 1191–1196. 1 indexed citations
6.
Dovom, Marzieh Rostami, et al.. (2023). The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS). Diagnostics. 13(17). 2814–2814. 8 indexed citations
7.
Ziaeefar, Pardis, Abbas Basiri, Moein Zangiabadian, et al.. (2023). Medical Expulsive Therapy for Pediatric Ureteral Stones: A Meta-Analysis of Randomized Clinical Trials. Journal of Clinical Medicine. 12(4). 1410–1410. 6 indexed citations
8.
Bostanghadiri, Narjess, et al.. (2023). COVID‐19: An Overview of SARS‐CoV‐2 Variants—The Current Vaccines and Drug Development. BioMed Research International. 2023(1). 1879554–1879554. 8 indexed citations
9.
10.
Ziaeefar, Pardis, Amir Hashem Shahidi Bonjar, Mitra Ghazizadeh Ahsaie, et al.. (2022). The efficacy of mouthwashes in reducing SARS-CoV-2 viral loads in human saliva: A systematic review. New Microbes and New Infections. 49-50. 101064–101064. 4 indexed citations
11.
12.
Kolahi, Ali‐Asghar, Maryam Akhgari, Farzad Gheshlaghi, et al.. (2021). COVID‐19 pandemic and methanol poisoning outbreak in Iranian children and adolescents: A data linkage study. Alcoholism Clinical and Experimental Research. 45(9). 1853–1863. 18 indexed citations
13.
Abrishami, Alireza, et al.. (2021). Rosai‐Dorfman disease: A case report of asymptomatic isolated renal involvement. SHILAP Revista de lepidopterología. 9(7). e04132–e04132. 3 indexed citations
14.
Bostanghadiri, Narjess, Pardis Ziaeefar, Fatemeh Sameni, et al.. (2021). The controversial association of gut and urinary microbiota with kidney stone formation. Microbial Pathogenesis. 161(Pt A). 105257–105257. 11 indexed citations
15.
Zamani, Nasim, et al.. (2021). Correction to: Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial. European Journal of Clinical Pharmacology. 77(4). 555–556. 1 indexed citations
16.
Ziaeefar, Pardis, et al.. (2021). Comparing the Clinical Characteristics, Laboratory Findings, and Outcomes between Epidemic and Episodic Methanol Poisoning Referrals; a Cross-sectional Study.. SHILAP Revista de lepidopterología. 9(1). e46–e46. 3 indexed citations
17.
Zamani, Nasim, et al.. (2020). Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial. European Journal of Clinical Pharmacology. 77(4). 547–554. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hormat Rahimzadeh Breakdown of academic impact, for papers by Akash Sharma Breakdown of academic impact, for papers by Edward Gaynor Breakdown of academic impact, for papers by Paloma Oliver Breakdown of academic impact, for papers by Ailbhe Tarrant Breakdown of academic impact, for papers by Nicolas De Schryver Breakdown of academic impact, for papers by Vishwanath Biradar Breakdown of academic impact, for papers by Robin Neubauer Breakdown of academic impact, for papers by Jodie L. Hurwitz Breakdown of academic impact, for papers by Marie-Hélène Masse
Rankless by CCL
2026